Yoshe Clinical Operations — Global CRO · SMO · Training
🇬🇧 UK 🇺🇸 USA 🇪🇺 EU 🌏 APAC 🇦🇺 AUS
Global CRO · SMO · Clinical Academy

Advancing Clinical Research Worldwide

Yoshe Clinical Operations — a hybrid CRO and SMO registered in England & Wales and the United States — delivers full-lifecycle clinical trial management with embedded quality systems, inspection-ready teams, and global regulatory expertise.

ICH-GCP E6(R3) MHRA EMA US FDA EU CTR 536/2014 GDPR
Clinical research team working in a modern laboratory
Phase I–IV
Clinical Development
5+
Global Regions
120+
SOPs Maintained
3
Regulatory Authorities
ICH E6(R3) GCP Compliant EMA — European Medicines Agency US FDA — 21 CFR 312 MHRA — UK Regulatory Authority EU CTR No 536/2014 Medidata Rave EDC Partner Risk-Based Quality Management Yoshe Clinical Academy — GCP Training APAC · North America · Europe · Australia GDPR / UK GDPR Compliant ICH E6(R3) GCP Compliant EMA — European Medicines Agency US FDA — 21 CFR 312 MHRA — UK Regulatory Authority EU CTR No 536/2014 Medidata Rave EDC Partner Risk-Based Quality Management Yoshe Clinical Academy — GCP Training APAC · North America · Europe · Australia GDPR / UK GDPR Compliant
Clinical professionals reviewing research data
2019
Founded with a clear vision to revolutionise clinical research through innovation & expertise
Who We Are

A New Standard for Clinical Excellence

Yoshe Clinical Operations was founded to address the growing need for efficient, reliable clinical trial management for pharma, biotech, and medical device manufacturers worldwide. We combine CRO depth with SMO agility — delivering high-quality, timely, and cost-effective solutions tailored to every client's unique needs.

🎯

Our Mission

To deliver comprehensive, inspection-ready clinical trial management from first-in-human to post-marketing, supporting sponsors from Phase I through Phase IV with embedded quality and compliance.

🔭

Our Vision

To be the most trusted hybrid CRO-SMO for emerging and mid-sized biopharmaceutical companies seeking global reach with UK and EU sites as their regulatory gateway.

⚖️

Our Values

Quality without compromise. Regulatory precision. Innovation in every process. Transparency with clients, sites, and participants at every stage.

🇬🇧
Yoshe Clinical Operations Ltd
Registered in England & Wales · Companies House · yoshe.co.uk

Our UK entity serves as the European and MHRA regulatory hub — managing clinical research sites across NHS Trusts, primary care networks, and dedicated research units across England, Scotland, Wales, and the EU. Operating under post-Brexit MHRA pathways and EU CTR 536/2014 through dual-jurisdiction compliance.

MHRA EMA EU CTR GDPR HRA ICH E6(R3)
One global
organisation.
Two entities.
🇺🇸
Yoshe Clinical Operations LLC
Registered in the United States · Medidata CRO Partner · yosheclinical.com

Our US entity enables full FDA IND pathway management, connecting North American sponsors with UK and EU sites. As a registered Medidata CRO Partner, we leverage Rave EDC, CTMS, eTMF, and eCOA technology infrastructure to run compliant, data-driven studies across APAC, North America, Europe, and Australia.

US FDA 21 CFR 312 Medidata Partner IND Studies APAC ICH E6(R3)
01 / VISION

Revolutionising Clinical Research Through Innovation

We envision a world where breakthrough therapies reach patients faster. Yoshe exists to remove the friction between scientific discovery and regulatory approval — providing the infrastructure, expertise, and quality systems that sites and sponsors need to execute exceptional clinical trials.

02 / MISSION

Delivering Quality, Speed & Compliance at Every Stage

To provide high-quality, timely, and cost-effective clinical trial management solutions tailored to each client's unique needs. From site activation and QMS design to study close-out and inspection readiness — we are with you at every step of the clinical development journey.

03 / GOALS

Building the Global Standard for Site-Level Excellence

Expand the Yoshe site network across UK, EU, North America, APAC, and Australia. Develop Yoshe Clinical Academy into a globally recognised GCP training provider. Achieve Medidata Elite Partner status. Establish Yoshe as the benchmark hybrid CRO-SMO for emerging biopharma sponsors.

What We Do

Full-Lifecycle Clinical Services

From first-in-human Phase I studies through Phase IV post-marketing trials, our integrated service model covers every function required for compliant, high-quality clinical research.

01
⚗️
Clinical Development

End-to-end Phase I–IV clinical trial management with full sponsor liaison, protocol oversight, and medical monitoring coordination.

  • Phase I–IV management
  • Protocol design support
  • Medical monitoring
  • Adaptive trial design
02
📋
Quality Management Systems

Full-function QMS deployment — 120+ SOPs across 12 categories, CAPA, audits, deviation management, and inspection readiness.

  • 120+ SOP suite
  • RBQM framework
  • Internal audit programme
  • Inspection readiness
03
🏥
Site Management (SMO)

Comprehensive site activation, management, and close-out across UK NHS Trusts, EU research centres, and global site networks.

  • Site feasibility & activation
  • CTA/REC submissions
  • Ongoing site oversight
  • Study close-out
04
⚖️
Regulatory Affairs

Strategic regulatory submissions and intelligence across MHRA, EMA/CTIS, and US FDA — from IND/CTA to end-of-trial notifications.

  • MHRA CTA applications
  • EU CTIS submissions
  • FDA IND management
  • Safety reporting
05
💾
Data Management & Technology

Medidata Rave EDC, CTMS, eTMF, eCOA, and LMS — fully validated clinical technology ecosystems aligned with 21 CFR Part 11 and ALCOA+.

  • Medidata Rave EDC
  • eTMF / eISF
  • CTMS oversight
  • Data governance
06
✍️
Medical Writing & Consulting

ICH E3-compliant CSRs, protocols, investigator brochures, regulatory submissions, and scientific publications for global filings.

  • Clinical Study Reports
  • Protocol authoring
  • Regulatory documents
  • Strategic consulting
Compliance Framework

Aligned with Global Regulatory Authorities

Every Yoshe process, SOP, and deliverable is built for multi-jurisdictional compliance — so your sites are always inspection-ready across all applicable regulatory frameworks.

European Medicines Agency
EU CTR 536/2014, CTIS submissions, EudraVigilance safety reporting, and EMA inspection readiness for EU member state studies.
US Food & Drug Administration
IND/IDE applications, 21 CFR Parts 11, 50, 56, 312 & 812 compliance, FDA safety reporting, and form FDA 1572 obligations.
UK Medicines & Healthcare products Regulatory Agency
UK CTA applications, HRA approvals, REC submissions, SUSAR reporting, and post-Brexit UK clinical trials regulation compliance.
E6(R3) — Effective 2025
Full alignment with ICH E6(R3) including Annex 1 for interventional trials, QbD principles, RBQM, and decentralised trial guidance.
ICH E6(R3) — GCP for interventional trials, effective July 2025 (EMA) / September 2025 (FDA)
EU CTR 536/2014 — Clinical Trials Regulation, CTIS portal submissions
UK Clinical Trials Regulations — SI 2004/1031 & post-Brexit MHRA framework
FDA 21 CFR 312 / 812 — IND and IDE applications and maintenance
GDPR / UK GDPR — Data protection for clinical trial participants
ICH E8(R1) — Quality by Design, Critical to Quality factors
ICH E2A / E2F — SUSAR and DSUR pharmacovigilance obligations
21 CFR Part 11 — Electronic records and electronic signatures validation
EU-US Data Privacy Framework — Cross-border data transfer 2023
ICH E3 — Clinical Study Report (CSR) structure and content
Global Reach

Operating Across Four Continents

As a Medidata-registered CRO partner with presence in the UK, USA, EU, APAC, and Australia, Yoshe connects sponsors to inspection-ready research sites anywhere in the world.

🇬🇧
United Kingdom
NHS Trusts, primary care networks, Phase I–IV units. Post-Brexit MHRA dual pathway.
MHRA · EMA · FDA
🇪🇺
European Union
20+ EU member state sites. CTIS-registered studies, EudraVigilance reporting.
EMA · EU CTR · FDA
🇺🇸
North America
US LLC entity enables full IND pathway and FDA 21 CFR 312 compliant operations.
US FDA · ICH GCP
🌏
APAC & Australia
Strategic site partnerships across Asia Pacific and Australia via Medidata network.
TGA · ICH GCP
Phase
I–IV
Full Development CoverageFirst-in-human through post-marketing surveillance across all therapeutic areas.
3
Major Regulatory AuthoritiesSimultaneous MHRA, EMA, and FDA compliance for global studies from UK sites.
13
Therapeutic AreasOncology, CNS, Cardiovascular, Rare Disease, Immunology, Vaccines and more.
120+
SOPs MaintainedFull functional SOP suite aligned with ICH E6(R3) and all applicable regulatory guidance.
Therapeutic Expertise

Deep Scientific Expertise Across Therapeutic Areas

Our team brings specialised knowledge across 13 therapeutic domains — ensuring protocol feasibility, site selection, and patient recruitment strategies are grounded in real-world clinical understanding.

Oncology Cardiovascular CNS / Neurology Rare Disease Immunology Diabetes & Metabolic Vaccines Respiratory Bone / Osteoporosis Endocrinology Orthopedics Devices & Diagnostics Dermatology Gastroenterology Haematology Infectious Disease Ophthalmology Paediatrics
📗
GCP Foundation & Refresher Programme

ICH E6(R3)-aligned GCP training for site staff, investigators, and sponsor personnel. Available as blended LMS + classroom.

E6(R3)
🔬
Clinical Research Associate (CRA) Programme

Comprehensive CRA training covering source data verification, monitoring visits, RBQM, and regulatory submissions.

RBQM
⚖️
Global Regulatory Affairs Curriculum

Multi-jurisdictional regulatory training covering EMA, FDA, MHRA, EU CTR, ICH guidelines, and post-Brexit pathways.

Multi-Reg
🏥
Study Coordinator Professional Development

Site-level professional competency programme for clinical research coordinators covering consent, data entry, and IP management.

Site-Level
💻
Medidata Systems Training

Hands-on training in Rave EDC, CTMS, eTMF, and eCOA — delivered in alignment with 21 CFR Part 11 validation requirements.

Medidata
Yoshe Clinical Academy

Building the Next Generation of Clinical Research Professionals

The Yoshe Clinical Academy delivers ICH E6(R3)-aligned training programmes through our LMS-powered blended learning platform — equipping every team member with the knowledge and competencies required for inspection-ready clinical research.

LMS-Delivered Learning

Flexible online courses with automated competency tracking and digital certification.

Competency Assessment

Rigorous assessment frameworks aligned with GCP delegation requirements.

Inspection-Ready Records

Audit-trail training records maintained in compliance with ICH E6(R3) 2.8.

Global Curriculum

MHRA, EMA, and FDA curriculum tracks adapted for each regulatory jurisdiction.

Corporate Compliance

Our Compliance Commitments

Every engagement with Yoshe is underpinned by a robust compliance architecture — from data governance and ethics to quality assurance and inspection readiness.

🔒
Data Protection & GDPR

Full GDPR and UK GDPR compliance. DPIA for every study. Data Processing Agreements with all sponsors. EU-US Data Privacy Framework adherent.

  • DPIA completed per study
  • 72-hour breach notification
  • Cross-border transfer compliance
  • Subject access request management
📊
Quality Assurance

Risk-based quality management aligned with ICH E6(R3) Section 5. Annual internal audit programme. CAPA system with root cause analysis.

  • RBQM framework
  • Annual audit programme
  • KPI and quality metrics reporting
  • Deviation management system
🌿
Ethics & Patient Rights

ICH E6(R3) 4.8-aligned informed consent processes. Vulnerability protection. IRB/REC oversight for all studies. Patient diversity and inclusion commitment.

  • IRB/REC approved consent
  • eConsent capability
  • Diversity inclusion programme
  • Patient rights framework
🏛️
Regulatory Integrity

Full transparency with MHRA, EMA, and FDA. Annual progress reports submitted on schedule. Serious adverse event reporting within mandatory timelines.

  • SUSAR within 7/15 days
  • Annual progress reports
  • Protocol amendment notifications
  • End-of-trial notifications
🖥️
Technology Validation

All computerised systems validated per 21 CFR Part 11 and EMA Annex 11. GAMP5 principles applied. Full audit trail integrity for all electronic records.

  • 21 CFR Part 11 compliant
  • GAMP5 validation
  • ALCOA+ data integrity
  • Electronic audit trails
📁
Archiving & Retention

15-year archive obligations maintained per EU CTR, MHRA, and FDA requirements. Secure eTMF and eISF archiving. Results disclosed on CTIS and ClinicalTrials.gov.

  • 15-year retention policy
  • eTMF final QC review
  • CTIS results disclosure
  • ClinicalTrials.gov registration
✦ Technology Partnership
Proud Medidata CRO Partner — Powered by Rave & Intelligent Clinical Platform

Yoshe Clinical Operations LLC is a registered partner on the Medidata CRO Partner Programme. Our studies run on Medidata Rave EDC, CTMS, eTMF, and eCOA — providing sponsors with industry-leading data quality, real-time oversight, and seamless regulatory submission-ready data packages.

Get in Touch

Partner with Yoshe Clinical

Whether you are a sponsor seeking a compliant CRO partner, a research site exploring SMO support, or a professional interested in our Academy — we'd like to hear from you.

United Kingdom — Ltd
🇬🇧
UK Entity
Yoshe Clinical Operations Ltd
Registered in England & Wales
🌐
UK Website
📧
United States — LLC
🇺🇸
US Entity
Yoshe Clinical Operations LLC
Medidata CRO Partner
🌐
Global Website
🔗
Medidata Partner
Connect With Us
📋 Regulatory Coverage
MHRA EMA US FDA ICH E6(R3) EU CTR GDPR